borderline significantp = 0.0485
However, with the same system administered three times (at days 4, 8, and 12 post-tumor inoculation), extension of survival ( Figure 8 I) became borderline significant (p = 0.0485).
However, with the same system administered three times (at days 4, 8, and 12 post-tumor inoculation), extension of survival ( Figure 8 I) became borderline significant (p = 0.0485).
28 Despite decreased number of lung lesions, the observed animal survival for two-round oncolytic therapy did not reach statistical significance.